Acute Leukemias IV: Prognostic Factors and Treatment Strategies (Haematology and Blood Transfusion Hämatologie und Bluttransfusion) (v. 4)
This 4th of a series of volumes again provides the state of the art in characterization and treatment of acute leukemias. The therapeutic progress is reflected by updates from major prospective clinical studies. The role of chemotherapy modi- fications and of bone marrow transplantation is elucidated and compared. Among prognostic factors the Philadelphia chromosome and bcr-abl gene rearrangement emerged as the most powerful risk factor in acute lymphoblastic leukemia. Molecularas well as immunologic leukemic cell markers open ways to monitor residual leukemia in clinical remission. Differentiation induction by retinoids represent a novel therapeutic principal as does the modulatioo
List Price: $ 225.00
Price: $ 225.00
Leukemia — Comprehensive overview covers symptoms, causes, risk factors, treatment of this blood-related cancer.
Acute Leukemias IV: Prognostic Factors and Treatment Strategies (Haematology and Blood Transfusion Hämatologie und Bluttransfusion) (v. 4)
Orignal From: Acute Leukemias IV: Prognostic Factors and Treatment Strategies (Haematology and Blood Transfusion Hämatologie und Bluttransfusion) (v. 4)
No comments:
Post a Comment